KLH in Clinical Trials

Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.

Clinical trial links are intended for informational purposes only, and are not solicitations for any study nor provided for the purposes of giving medical advice. See Terms of Use for this site.

(in order by date)

Entries in Adjuvant GM-CSF (33)

Wednesday
Dec212011

NCT01498328

A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma (ReACT)

Conditions: Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
Sponsors: Celldex Therapeutics
Phase II

Monday
Nov212011

NCT01480479

Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma (ACT IV)

Conditions: Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
Sponsors: Celldex Therapeutics
Phase III

Wednesday
Nov242010

NCT01250470

Survivin Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma

Phase I Study of Safety, Tolerability and Immunological Effects of SVN53-67/M57-KLH (SurVaxM) in Patients with Survivin-Positive Malignant Gliomas

Conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Mixed Glioma, Recurrent Adult Brain Tumor
Sponsors: Roswell Park Cancer Institute
Collaborators: NCI, MimiVax
Phase I

Wednesday
Aug252010

NCT01189383

IL15 Dendritic Cell Vaccine for Patients With Resected Stage IIIc and Stage IV Melanoma

Conditions: Stage IIIc/IV Melanoma
Sponsors: Baylor Research Institute
Phase I, II

Friday
Jul302010

NCT01174082

Donor Lymphocyte Infusion for Myeloma

Conditions: Myeloma
Sponsors: M.D. Anderson Cancer Center
Phase 2

Tuesday
Mar252008

NCT00643097

Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Conditions: Brain and Central Nervous System Tumors
Sponsors: Duke University, National Institute of Neurological Disorders and Stroke
Phase II

Thursday
Feb212008

NCT00621036

Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma

Conditions: Brain and Central Nervous System Tumors, Lymphoma, Lymphoproliferative Disorder, Small Intestine Cancer
Sponsors: Simmons Cancer Center
Phase II

Wednesday
Dec122007

NCT00574886

Wednesday
Sep122007

NCT00530140

Idiotypic Vaccination for Follicular Lymphoma Patients

Conditions: Follicular Lymphoma, First Relapse/Progression
Sponsors: Instituto Cientifico y Tecnologico de Navarra, Universidad de Navarra
Phase II

Tuesday
Jul312007

NCT00510471